|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Angioedema |
|
Rhinitis, allergic |
|
Urticaria |
| |
|
|
SIDE EFFECTS:
|
|
seizures |
|
sinus tachycardia |
|
urinary retention |
|
weakness |
|
xerophthalmia |
|
xerostomia |
|
abdominal pain |
|
anorexia |
|
blurred vision |
|
confusion |
|
constipation |
|
diarrhea |
|
dizziness |
|
drowsiness |
|
fatigue |
|
headache |
|
hypertension |
|
hypotension |
|
impaired cognition |
|
insomnia |
|
nausea/vomiting |
|
palpitations |
|
restlessness |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
asthma |
|
bladder obstruction |
|
cardiac disease |
|
children |
|
chronic obstructive pulmonary disease (COPD) |
|
closed-angle glaucoma |
|
contact lenses |
|
driving or operating machinery |
|
elderly |
|
GI obstruction |
|
hepatic disease |
|
pregnancy |
|
prostatic hypertrophy |
|
|
ADULT DOSE:
|
|
Antihistaminic (H -receptor)-Oral, 1.34 mg two times a day or 2.68 mg one to three times a day as needed.
Note: Clemastine is indicated for dermatologic conditions at the 2.68-mg dosage level only. |
|
MAXIMUM ADULT DOSE:
|
|
Up to 8.04 mg daily.
|
|
PEDIATRIC DOSE:
|
|
Antihistaminic (H -receptor)-Children up to 6 years of age: Dosage has not been established.
Children 6 to 12 years of age: Oral, 670 mcg (0.67 mg) to 1.34 mg two times a day, not to exceed 4.02 mg per day.
Note: Clemastine is indicated for dermatologic conditions at the 1.34-mg dosage level only. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Antihistaminic (H -receptor)-Oral, 1.34 mg two times a day or 2.68 mg one to three times a day as needed.
Note: Clemastine is indicated for dermatologic conditions at the 2.68-mg dosage level only. |
|
|
|
|